The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
Crowe
B A
BA
Medical Research Center, Immuno AG, Orth, Austria.
Enzersberger
O
O
Schober-Bendixen
S
S
Mitterer
A
A
Mundt
W
W
Livey
I
I
Pabst
H
H
Kaeser
R
R
Eibl
M
M
Eibl
J
J
D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology*; D003429:Cross Reactions; D005407:Flagella / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000032:analysis / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects; D011552:Pseudomonas Infections / Q000276:immunology*; D011550:Pseudomonas aeruginosa / Q000276:immunology*
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D007074:Immunoglobulin G